Cart
sales@molnova.com
Dazmegrel
CAS No. 76894-77-4
Dazmegrel( —— )
Catalog No. M34567 CAS No. 76894-77-4
Dazmegrel (UK 38,485) is a potent and specific thromboxane A2 (TXA2) synthase inhibitor for the prevention of increased whole platelet aggregation in normal pregnancy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 686 | In Stock |
|
| 10MG | 938 | In Stock |
|
| 25MG | 1444 | In Stock |
|
| 50MG | 1841 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDazmegrel
-
NoteResearch use only, not for human use.
-
Brief DescriptionDazmegrel (UK 38,485) is a potent and specific thromboxane A2 (TXA2) synthase inhibitor for the prevention of increased whole platelet aggregation in normal pregnancy.
-
DescriptionDazmegrel (UK 38,485) is a potent and specific thromboxane A2 (TXA2) synthase inhibitor for the prevention of increased whole platelet aggregation in normal pregnancy.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorPPAR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number76894-77-4
-
Formula Weight283.33
-
Molecular FormulaC16H17N3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=C(CN2C=CN=C2)C2=C(C=CC=C2)N1CCC(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Choline Fenofibrate
A PPARα agonist used for treatment of hyperlipidemia.
-
Mifobate
Mifobate is a potent and specific antagonist of PPARγ. Mifobate shows antiobesity, antidiabetic and antiatherosclerotic effects.
-
Reglitazar
Reglitazar (JTT-501) is a dual PPARα and PPARγ agonist that is used to study diabetes.
